{"id":"NCT01220726","sponsor":"Weill Medical College of Cornell University","briefTitle":"Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction","officialTitle":"Randomized Double-blind Placebo Controlled Trial of Intradetrusor Injections of Botox for the Treatment of Refractory Overactive Bladder Secondary to Benign Prostatic Obstruction-BTX0621","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-06","primaryCompletion":"2011-06","completion":"2012-11-13","firstPosted":"2010-10-14","resultsPosted":"2019-02-26","lastUpdate":"2019-02-26"},"enrollment":30,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Overactive Bladder"],"interventions":[{"type":"DRUG","name":"Botox","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Botox","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a prospective, randomized, double-blind study comparing intravesical injection of BOTOX to placebo. Study subjects will be randomized (1:1 ratio) to one of the following treatment groups:","primaryOutcome":{"measure":"Urinary Frequency","timeFrame":"From Baseline to Day 270","effectByArm":[{"arm":"Placebo","deltaMin":10.5,"sd":null},{"arm":"Botox","deltaMin":11,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"MALE","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":["Acute Urinary retention","Hematuria","Urinary tract infection"]}}